When are Alternatives to High Dose Chemotherapy Reasonable?

Track: BMT Tandem "Scientific" Meeting
Thursday, February 27, 2014, 10:30 AM-12:00 PM
Texas B (Gaylord Texan)
Raymond Comenzo, MD , Hematology/Oncology, Tufts Medical Center, Boston, MA
Audio File Recorded Presentation
Disclosures:
R. Comenzo, Takeda, Millenium, Advisor: Consultancy
Prothena, Clinical Trial PI: Research Funding
TEVA, Clinical Trial PI: Research Funding
See more of: Amyloidosis: Should Our Treatment Approaches Be More Personalized?
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation | Next Presentation >>